Nucor earnings beat by $0.08, revenue fell short of estimates
VANCOUVER - Methanex Corporation (TSX:MX) (NASDAQ:MEOH), a $2.36 billion market cap company with "GREAT" financial health according to InvestingPro analysis, has received regulatory clearance for its planned acquisition of OCI Global’s international methanol business after the review period under the U.S. Hart-Scott-Rodino Antitrust Act expired, the company announced Thursday.
The transaction is expected to close on June 27, pending satisfaction of customary closing conditions. All required regulatory approvals have now been obtained.
"We are pleased to have received regulatory clearance and look forward to closing the transaction and welcoming new team members to Methanex," said Rich Sumner, President and CEO of Methanex. "Given our extensive integration planning, we expect to move quickly upon closing to deliver the strategic benefits of this acquisition."
The deal, first announced earlier this year, represents a significant expansion for Methanex, which describes itself as the world’s largest producer and supplier of methanol globally. The Vancouver-based company, which generated $3.7 billion in revenue over the last twelve months and has maintained dividend payments for 24 consecutive years, has been preparing for the integration of OCI Global’s methanol operations.
Financial terms and specific details regarding the assets being acquired were not disclosed in the company’s statement.
The announcement comes as Methanex continues its strategy of strengthening its position in the global methanol market. Trading at a P/E ratio of 10.45 and currently undervalued according to InvestingPro Fair Value analysis, the acquisition is expected to increase Methanex’s production capacity and geographic reach. For detailed valuation metrics and 8 additional key insights about Methanex, visit InvestingPro.
This information is based on a press release issued by Methanex Corporation.
In other recent news, Methanex Corporation has been the subject of several analyst evaluations and strategic developments. Piper Sandler upgraded Methanex’s stock rating from Neutral to Overweight and increased the price target to $48, citing positive outcomes from the last quarter and an improved outlook for midcycle earnings potential. In contrast, Jefferies maintained a Buy rating but lowered the price target to $45, reflecting expectations of pricing moderation in the methanol market. Raymond James also reduced its price target from $62 to $40 but retained an Outperform rating, highlighting concerns about a weaker macroeconomic environment and the impact of Methanex’s acquisition of OCI N.V.’s methanol and ammonia assets.
JPMorgan initiated coverage on Methanex with a Neutral rating and a $33 price target, recognizing the company’s focus on cost management and geographic flexibility. RBC Capital maintained a Sector Perform rating with a $55 price target, noting the economic uncertainty and the potential impact of Methanex’s pending acquisition. Despite these varied assessments, Methanex’s stock valuation is seen as attractive by some analysts, particularly for those with a positive outlook on the global economy. Investors are closely monitoring Methanex’s strategic moves and market conditions as they evaluate the company’s long-term prospects.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.